Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects

被引:103
作者
Moriya, Y
Nakamura, T
Horinouchi, M
Sakaeda, T
Tamura, T
Aoyama, N
Shirakawa, T
Gotoh, A
Fujimoto, S
Matsuo, M
Kasuga, M
Okumura, K [1 ]
机构
[1] Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 650, Japan
[2] Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, Kyoto 6078414, Japan
[3] Kobe Univ, Sch Med, Dept Endoscopy, Kobe, Hyogo, Japan
[4] Kobe Univ, Sch Med, Dept Clin Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan
[5] Kobe Univ, Sch Med, Int Ctr Med Res, Chuo Ku, Kobe, Hyogo 6500017, Japan
[6] Kobe Univ, Grad Sch Med, Fac Med,Div Diabet Digest & Kidney Dis, Dept Clin Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan
[7] Kobe Univ, Grad Sch Med, Dept Organ Therapeut, Fac Med,Div Urol,Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
P-glycoprotein; multidrug resistance-associated protein; genetic polymorphism; gene expression; duodenal enterocyte;
D O I
10.1248/bpb.25.1356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, we examined whether polymorphisms in the ATP-binding cassette (ABC) transporter genes, MDR1, MRP1 and MRP2, were associated with their respective mRNA expression levels in duodenal enterocytes of 13 healthy Japanese volunteers. MDR1 genotypes of T-129C, G2677(A,T) and C3435T, MRP1 genotypes of G128C, C218T, G2168A and G3173A, and MRP2 genotypes of C-24T, G1249A, C2302T, C2366T and G4348A were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or direct sequencing. Mutations T-129C, G2677(A,T) and C3435T of MDR1 gene were found at allele frequencies of 2/26, 16/26 and 12/26, respectively. Mutations G2168A of the MRP1 gene and C-24T of the MRP2 gene were also found at allele frequencies of 1/26 and 6/26, respectively, whereas other mutations were not detected in MRP1 and MRP2 genes. The relative concentrations (mean+/-S.E.) of MDR1 mPNA to villin mRNA were 0.38+/-0.15, 0.56+/-0.14 and 1.13+/-0.42 in the subjects with C/C-3435, C/T-3435 and T/T-3435, respectively, which supported the lower serum concentrations of digoxin after single oral administration in the subjects with the mutant T-allele at position 3435. Genetic collaboration between positions 3435 and 2677 was suggested, and those in G/G(2677), G/(A,T)(2677) and T/(A,T)(2677) were 0.16+/-0.05, 1.10+/-0.40, and 0.63+/-0.16, respectively (p = 0.107). However, there was no remarkable effect of the G2168A of the MRP1 gene or of C-24T of the MRP2 gene on the relative MRP1 or MRP2 mRNA concentrations, respectively.
引用
收藏
页码:1356 / 1359
页数:4
相关论文
共 16 条
  • [1] Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
    Cascorbi, I
    Gerloff, T
    Johne, A
    Meisel, C
    Hoffmeyer, S
    Schwab, M
    Schaeffeler, E
    Eichelbaum, M
    Brinkmann, U
    Roots, I
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 169 - 174
  • [2] The effect of rifampin treatment on intestinal expression of human MRP transporters
    Fromm, MF
    Kauffmann, HM
    Fritz, P
    Burk, O
    Kroemer, HK
    Warzok, RW
    Eichelbaum, M
    Siegmund, W
    Schrenk, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) : 1575 - 1580
  • [3] Hirohashi T, 2000, J PHARMACOL EXP THER, V292, P265
  • [4] Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
    Hoffmeyer, S
    Burk, O
    von Richter, O
    Arnold, HP
    Brockmöller, J
    Johne, A
    Cascorbi, I
    Gerloff, T
    Roots, I
    Eichelbaum, M
    Brinkmann, U
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3473 - 3478
  • [5] Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects
    Ito, S
    Ieiri, I
    Tanabe, M
    Suzuki, A
    Higuchi, S
    Otsubo, K
    [J]. PHARMACOGENETICS, 2001, 11 (02): : 175 - 184
  • [6] Identification of functionally variant MDR1 alleles among European Americans and African Americans
    Kim, RB
    Leake, BF
    Choo, EF
    Dresser, GK
    Kubba, SV
    Schwarz, UI
    Taylor, A
    Xie, HG
    McKinsey, J
    Zhou, S
    Lan, LB
    Schuetz, JD
    Schuetz, EG
    Wilkinson, GR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (02) : 189 - 199
  • [7] P-GLYCOPROTEIN GENE (MDR1) CDNA FROM HUMAN ADRENAL - NORMAL P-GLYCOPROTEIN CARRIES GLY185 WITH AN ALTERED PATTERN OF MULTIDRUG RESISTANCE
    KIOKA, N
    TSUBOTA, J
    KAKEHI, Y
    KOMANO, T
    GOTTESMAN, MM
    PASTAN, I
    UEDA, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (01) : 224 - 231
  • [8] Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
    Lown, KS
    Mayo, RR
    Leichtman, AB
    Hsiao, HL
    Turgeon, DK
    SchmiedlinRen, P
    Brown, MB
    Guo, WS
    Rossi, SJ
    Benet, LZ
    Watkins, PB
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) : 248 - 260
  • [9] LOWN KS, 1994, DRUG METAB DISPOS, V22, P947
  • [10] Genetic polymorphism in MDR-1:: A tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors
    Mickley, LA
    Lee, JS
    Weng, Z
    Zhan, ZR
    Alvarez, M
    Wilson, W
    Bates, SE
    Fojo, T
    [J]. BLOOD, 1998, 91 (05) : 1749 - 1756